Cardio-kidney-metabolic phenotypes determine residual cardiovascular risk after acute coronary syndromes

19 February 2026 (08:00 - 18:30)
Organised by: Logo
Congress Presentation Part of: Personalised PCI: special populations, innovative devices and tailored therapy Percutaneous Coronary Intervention (PCI) and Surgery EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

ESC 365 is supported by

ESC 365 is supported by